1. Home
  2. PN vs OPRX Comparison

PN vs OPRX Comparison

Compare PN & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PN
  • OPRX
  • Stock Information
  • Founded
  • PN 2011
  • OPRX 2006
  • Country
  • PN China
  • OPRX United States
  • Employees
  • PN N/A
  • OPRX N/A
  • Industry
  • PN
  • OPRX Business Services
  • Sector
  • PN
  • OPRX Consumer Discretionary
  • Exchange
  • PN NYSE
  • OPRX Nasdaq
  • Market Cap
  • PN N/A
  • OPRX 154.9M
  • IPO Year
  • PN 2025
  • OPRX N/A
  • Fundamental
  • Price
  • PN $2.70
  • OPRX $13.43
  • Analyst Decision
  • PN
  • OPRX Buy
  • Analyst Count
  • PN 0
  • OPRX 8
  • Target Price
  • PN N/A
  • OPRX $10.81
  • AVG Volume (30 Days)
  • PN 11.3K
  • OPRX 336.3K
  • Earning Date
  • PN 01-01-0001
  • OPRX 08-07-2025
  • Dividend Yield
  • PN N/A
  • OPRX N/A
  • EPS Growth
  • PN N/A
  • OPRX N/A
  • EPS
  • PN 0.02
  • OPRX N/A
  • Revenue
  • PN $49,864,047.00
  • OPRX $94,365,000.00
  • Revenue This Year
  • PN N/A
  • OPRX $14.44
  • Revenue Next Year
  • PN N/A
  • OPRX $10.63
  • P/E Ratio
  • PN $137.48
  • OPRX N/A
  • Revenue Growth
  • PN N/A
  • OPRX 20.66
  • 52 Week Low
  • PN $2.18
  • OPRX $3.78
  • 52 Week High
  • PN $4.45
  • OPRX $15.71
  • Technical
  • Relative Strength Index (RSI)
  • PN N/A
  • OPRX 48.16
  • Support Level
  • PN N/A
  • OPRX $12.20
  • Resistance Level
  • PN N/A
  • OPRX $13.42
  • Average True Range (ATR)
  • PN 0.00
  • OPRX 0.87
  • MACD
  • PN 0.00
  • OPRX -0.33
  • Stochastic Oscillator
  • PN 0.00
  • OPRX 12.82

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Share on Social Networks: